BSE filing, NSE: WELSPUNLIV. Summary written from the filing by ALFA Finder's alert engine.
Welspun Living Ltd: key numbers
- Share price
- ₹216.00
- Market cap
- ₹20,718 Cr
- Revenue (annual)
- ₹9,399 Cr
- Net profit (annual)
- ₹204.4 Cr
- P/E (TTM)
- 74.6×Sector 49.5×
- Promoter holding
- 63.77%-2.59% QoQ
- FII holding
- 9.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Welspun Living Ltd
All →Welspun Living Other Announcement
The company has filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Welspun Living Promoter Selling: ₹525.9 Cr
Welspun Living promoter, Welspun Group Master Trust, sold 2.45 crore shares worth ₹525.88 Crore via block deals on September 23, 2026.
- Value
- ₹525.9 Cr
- Promoter stake change
- -2.59%
Welspun Living Annual General Meeting
Welspun Living held its 41st Annual General Meeting on September 24, 2026. Shareholders approved financial statements, dividend, and several special business items.
Welspun Living Promoter Selling
Welspun Group Master Trust disposed 2,44,71,102 shares (2.59%) of Welspun Living via block deal. Post-transaction promoter holding falls to 63.26%.
- Promoter stake change
- -2.59%
Welspun Living Credit Rating
India Ratings upgraded Welspun Global Brands (material subsidiary) bank loan rating to IN AA+/Stable from IN A1+. The ₹900 Crore facility upgrade strengthens the subsidiary's credit standing.
Welspun Living Other Announcement
Welspun Living Limited issued letters to shareholders with unregistered e-mails, providing a web-link to access the Notice of the 41st AGM and FY 2025-26 Annual Report.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.